BioMarin to acquire Alesta Therapeutics for $275 million
Piotr Swat | Lightrocket | Getty ImagesCNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our...
HEALTH & FITNESS
Moderna, Merck cancer vaccine shows initial late-stage melanoma data
An experimental personalized cancer vaccine from Merck and Moderna showed positive initial results in its first-ever late-stage trial, the companies...
Hims & Hers CEO Andrew Dudum talks FTC lawsuit, GLP-1s, AI
Hims & Hers CEO Andrew Dudum defended the telehealth company amid a Federal Trade Commission lawsuit over its data sharing...
The startup using AI to help build custom treatments for rare diseases
Jacalyn Lee, founder of The DAND Alliance, and her youngest daughter Isla.Jacalyn LeeCNBC Cures is proudly underwritten by Alexion, AstraZeneca...
Court rules companies can’t import Gilead medications from overseas
Nikos Pekiaridis | Nurphoto | Getty ImagesA court ruling this week in favor of Gilead Sciences could significantly impact a...
Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'
Novo Nordisk CEO defended the company's decision to sue rival Eli Lilly over its weight-loss drug advertising. Source link
Trump ends Medicaid, CHIP funding for gender-affirming care for children
Supporters of transgender youth demonstrate outside Children's Hospital Los Angeles (CHLA) on February 6, 2025 in the wake of US...
We’re lifting our price target on Cardinal Health after issuing rosy profit guidance
Cardinal Health on Tuesday showed why the healthcare distributor belongs in our portfolio, delivering robust full-year earnings guidance that trumped...
Trump wants to split childhood shot up
President Donald Trump's latest executive order calls for splitting the measles, mumps and rubella, or MMR, vaccine into three separate...
Jazz Pharmaceuticals to buy Actio Biosciences for $820 million
Piotr Swat | Lightrocket | Getty ImagesCNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our...
Eli Lilly wins U.K. approval, challenging Wegovy weight-loss pill
Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S., allowing it to compete...
Trump signs vaccine executive order calling for fewer childhood shots
Secretary of Health and Human Services Robert F. Kennedy Jr. looks on as President Donald Trump speaks before signing an...
New genetic tests are catching rare diseases before symptoms start
Westend61 | Westend61 | Getty ImagesCNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism...
We like Boeing’s Archer deal. Plus, what to expect from this health stock
Every weekday, the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a...
Hunter Biden says Joe Biden’s cancer has spread, is ‘very debilitating’
President Joe Biden stands with his son Hunter Biden after the president arrived at the Delaware Air National Guard Base...
Jim Cramer highlights 5 investing themes — and the stocks to buy for each
CNBC's Jim Cramer said Thursday earnings season has revealed investing themes he thinks will produce the market's best buying opportunities."I...
Sen. Mitch McConnell says he’s left rehab, will work from home
Senator Mitch McConnell (R-KY) is seen during a Senate Committee on Appropriations, Subcommittee on Department of Defense budget hearing at...
CAMP4 advances rare disease treatment for SYNGAP1 into human trials
CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance...
Eli Lilly, Novo Nordisk earnings show widening divide in GLP-1 market
The Eli Lilly and Novo Nordisk logos.Mike Blake | Tom Little | ReutersThe diverging paths of two GLP-1 drugmakers were...
AstraZeneca-Bristol Myers merger talks explained
Pharma investors reeled this week from reports that AstraZeneca held merger talks with U.S. rival Bristol Myers Squibb, a move...
